Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma. 2015

N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

UI MeSH Term Description Entries
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077269 Lenalidomide A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-,3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione,CC 5013,CC-5013,CC5013,IMiD3 Cpd,Revimid,Revlimid
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell

Related Publications

N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
June 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
April 2011, Bone marrow transplantation,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
June 2012, Journal of chemotherapy (Florence, Italy),
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
August 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
April 2007, Annals of oncology : official journal of the European Society for Medical Oncology,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
June 2017, The Lancet. Haematology,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
December 2019, Bone marrow transplantation,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
January 2018, Acta haematologica,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
December 2021, Haematologica,
N Shah, and P F Thall, and P S Fox, and Q Bashir, and J J Shah, and S Parmar, and P Lin, and P Kebriaei, and Y Nieto, and U R Popat, and C M Hosing, and A Cornelison, and E J Shpall, and R Z Orlowski, and R E Champlin, and M H Qazilbash
January 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Copied contents to your clipboard!